JENBURKT PHARMACEUTICALS
|
The Current P/E Ratio of JENBURKT PHARMACEUTICALS is 17.32.
Share Price | ₹1,262.2 | Aug 04,2025 |
Market Cap | ₹555.3 Cr | |
Earnings-TTM | ₹32.1 Cr | TTM-Standalone Results |
Price/Earnings | 17.32x | Calculated as Market Cap/Earnings |
---|---|---|
Explore Stock Analytics |
Definition & Calculation of PE (Price/Earnings) ratio of JENBURKT PHARMACEUTICALS
P/E =
Market Capitalization
/ Net Income
or, using per-share numbers:
P/E = Stock Price /
Earnings Per Share (EPS)
Current Market Cap [ ₹555.3 Cr] as on Aug 04,2025
(/) Earnings [ ₹32.1 Cr] based on TTM-Standalone Results
(=) P/E Ratio [ 17.32x ]
Thus, for JENBURKT PHARMACEUTICALS , the investors are currently willing to pay 17.32 times earnings to own 1 share of the company.
PE Multiples are the most widely used valuation multiple in practice.
Since P/E ratio uses Net Income in the calculation, P/E multiples are not always reliable for valuing companies with negative earnings.
In such cases, you may consider using Price to Book ratio or Price to Sales ratio of JENBURKT PHARMACEUTICALS !
P/E ratios, also, would not adjust for differences in the capital structure between companies.
The chart below summarizes the trend in P/E Ratio of JENBURKT PHARMACEUTICALS over the last five years.
Historical PE (Price/Earnings) ratio chart of JENBURKT PHARMACEUTICALS
PE Ratio Performance Analysis for JENBURKT PHARMACEUTICALS
- JENBURKT PHARMACEUTICALS 's p/e ratio for fiscal years ending Mar2025 to Mar2021 averaged 12.06x.
- JENBURKT PHARMACEUTICALS 's operated at median p/e ratio of 11.71x from fiscal years ending March 2018 to 2022.
- Looking back at the last 5 fiscal years, JENBURKT PHARMACEUTICALS 's p/e ratio peaked in Mar2025 at 13.93x.
- JENBURKT PHARMACEUTICALS 's p/e ratio hit its five-year low in Mar2021 of 11.08x.
How does JENBURKT PHARMACEUTICALS 's P/E Ratio benchmark against top 10 peers in Pharmaceuticals & Drugs Industry?
Peer Comparison (Pharmaceuticals & Drugs Industry) | Earnings-TTM (Cr) | PE Ratio | Market Cap |
---|---|---|---|
JENBURKT PHARMACEUTICALS | 32.06 | 17.32 | 555.3 |
SUN PHARMACEUTICAL INDUSTRIES LTD | 10,411.50 | 37.82 | 393,731.0 |
DIVIS LABORATORIES LTD | 2,191.00 | 78.67 | 172,373.0 |
CIPLA LTD | 5,406.81 | 22.64 | 122,411.0 |
TORRENT PHARMACEUTICALS LTD | 2,002.00 | 61.08 | 122,285.0 |
DR REDDYS LABORATORIES LTD | 5,726.70 | 17.86 | 102,270.0 |
MANKIND PHARMA LTD | 1,905.51 | 56.93 | 108,482.0 |
ZYDUS LIFESCIENCES LTD | 4,614.80 | 20.93 | 96,568.3 |
LUPIN LTD | 3,306.26 | 26.01 | 86,005.5 |
AUROBINDO PHARMA LTD | 3,515.26 | 18.02 | 63,359.6 |
ABBOTT INDIA LTD | 1,414.44 | 51.14 | 72,332.7 |
Pharmaceuticals & Drugs Industry Benchmark (Top 10) PE Analysis vs JENBURKT PHARMACEUTICALS 's P/E Ratio
Top 10 Industry Peers | PE Ratio |
---|---|
Min industry PE | 17.32x |
Max industry PE | 78.67x |
Median industry PE | 26.01x |
Average industry PE | 37.13x |
You may also like the below Video Courses